Paying user area
Try for free
Shockwave Medical Inc. pages available for free this week:
- Balance Sheet: Assets
- Balance Sheet: Liabilities and Stockholders’ Equity
- Cash Flow Statement
- Common-Size Income Statement
- Analysis of Solvency Ratios
- Analysis of Short-term (Operating) Activity Ratios
- Analysis of Long-term (Investment) Activity Ratios
- Net Profit Margin since 2019
- Total Asset Turnover since 2019
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Shockwave Medical Inc. for $22.49.
This is a one-time payment. There is no automatic renewal.
We accept:
Calculation
Operating profit margin | = | 100 | × | Income (loss) from operations1 | ÷ | Revenue1 | |
---|---|---|---|---|---|---|---|
Dec 31, 2023 | = | 100 | × | ÷ | |||
Dec 31, 2022 | = | 100 | × | ÷ | |||
Dec 31, 2021 | = | 100 | × | ÷ | |||
Dec 31, 2020 | = | 100 | × | ÷ | |||
Dec 31, 2019 | = | 100 | × | ÷ |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).
1 US$ in thousands
- Income (loss) from operations
- The operational income exhibited a marked improvement over the period analyzed. Starting with a substantial loss of approximately $51.8 million in 2019, the loss deepened to around $65.7 million in 2020. However, a significant turnaround occurred in 2021, where the loss narrowed considerably to $871 thousand, followed by a switch to positive operational income in 2022 and 2023, reaching $124.1 million and $159.1 million respectively. This trend indicates effective cost control or revenue growth leading to operational profitability in the latter years.
- Revenue
- Revenue increased sharply throughout the five-year period. Beginning at $42.9 million in 2019, revenue grew to $67.8 million in 2020 and then surged significantly in 2021 to $237.1 million. This upward trajectory continued with revenues reaching $489.7 million in 2022 and further expanding to $730.2 million in 2023. The consistent and substantial revenue growth suggests strong market demand and successful business expansion strategies.
- Operating profit margin
- The operating profit margin reflected the operational income trend with notable progression. The company operated at a significant negative margin of -120.76% in 2019 and a somewhat less negative margin of -96.86% in 2020. The margin nearly broke even in 2021 at -0.37%. A positive turnaround was achieved in 2022 with a 25.35% margin, followed by a slight decrease to 21.79% in 2023. These margin improvements suggest enhanced operational efficiency and profitability, although the slight margin contraction in 2023 may merit monitoring.
Comparison to Competitors
Shockwave Medical Inc. | Abbott Laboratories | Intuitive Surgical Inc. | Medtronic PLC | UnitedHealth Group Inc. | |
---|---|---|---|---|---|
Dec 31, 2023 | |||||
Dec 31, 2022 | |||||
Dec 31, 2021 | |||||
Dec 31, 2020 | |||||
Dec 31, 2019 |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31).